(Q40384862)

English

Efficacy and toxicity of intermediate-dose amphotericin B lipid complex as a primary or salvage treatment of fungal infections in patients with hematological malignancies

scientific article published on October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Efficacy and toxicity of intermediate-dose amphotericin B lipid complex as a primary or salvage treatment of fungal infections in patients with hematological malignancies (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

based on heuristic

inferred from title

author name string

Rodrigo Martino

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Montserrat Cortés

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Maricel Subirá

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Rocio Parody

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Estela Moreno

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jorge Sierra

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1429-1435

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Invasive fungal infections in hematology: new trends

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

Newer systemic antifungal agents : pharmacokinetics, safety and efficacy

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): a review of the literature

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

Overview of the lipid formulations of amphotericin B.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

Comparison of evidence of treatment effects in randomized and nonrandomized studies

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

Toward more effective antifungal therapy: the prospects of combination therapy.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500205486

21 January 2018

Identifiers

10.1080/10428190500205486

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40384862&oldid=1896719318"